EUPRAXIA PHARMACEUTICALS INC. (EPRX)
↓ Download CSV- Sector Manufacturing
- Incorporated A1
- Fiscal year ends Dec 31
In fiscal 2025, EUPRAXIA PHARMACEUTICALS INC. reported revenue of $0. The company ran a net loss. It held $86.15M in total assets against $5.70M in total liabilities.
Key ratios (FY2025)
-48.0%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | — | — |
| Net Income | -$38.58M | -$25.50M | -$28.22M | -$18.49M | — |
| EPS (Diluted) | $-1.03 | $-0.76 | $-1.17 | $-0.96 | — |
| Total Assets | $86.15M | $34.94M | $20.27M | $19.12M | — |
| Total Liabilities | $5.70M | $3.10M | $19.37M | $11.91M | — |
| Shareholders' Equity | $80.45M | $31.84M | $892.3K | $7.21M | $15.10M |
| Cash & Equivalents | $80.56M | $33.10M | $19.34M | $18.26M | — |
| Operating Cash Flow | -$28.55M | -$29.99M | -$20.75M | -$14.40M | — |
| Shares Outstanding | 51.94M | 35.64M | 27.28M | 21.59M | — |